Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IMMUNIC, INC. | 660,000 | reported | 16 Jul 2025 | tx 11+4,186,024 |
| Ovid Therapeutics Inc. | 168,750 | reported | 22 Feb 2024 | tx 13+1,163,373−17,344 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Jul 2025 | GRANT_AWARD | IMMUNIC, INC. | 330,000 | 0.00 USD | deriv |
| 16 Jul 2025 | GRANT_AWARD | IMMUNIC, INC. | 330,000 | 0.00 USD | deriv |
| 16 Jul 2025 | GRANT_AWARD | IMMUNIC, INC. | 660,000 | 0.00 USD | deriv |
| 16 Jul 2025 | GRANT_AWARD | IMMUNIC, INC. | 330,000 | 0.00 USD | deriv |
| 16 Jul 2025 | GRANT_AWARD | IMMUNIC, INC. | 660,000 | 0.00 USD | deriv |
| 05 Jun 2025 | PURCHASE | IMMUNIC, INC. | 12,512 | 0.79 USD | |
| 05 Jun 2025 | GRANT_AWARD | IMMUNIC, INC. | 595,000 | 0.00 USD | deriv |
| 04 Dec 2024 | GRANT_AWARD | IMMUNIC, INC. | 157,500 | 0.00 USD | deriv |
| 12 Jul 2024 | GRANT_AWARD | IMMUNIC, INC. | 500,000 | 0.00 USD | deriv |
| 22 Feb 2024 | GRANT_AWARD | Ovid Therapeutics Inc. | 28,125 | 0.00 USD | |
| 22 Feb 2024 | GRANT_AWARD | Ovid Therapeutics Inc. | 168,750 | 0.00 USD | deriv |
| 23 Feb 2023 | GRANT_AWARD | Ovid Therapeutics Inc. | 175,000 | 0.00 USD | deriv |
| 12 Sept 2022 | SALE | Ovid Therapeutics Inc. | 17,344 | 2.15 USD | |
| 08 Apr 2022 | GRANT_AWARD | Ovid Therapeutics Inc. | 10,000 | 0.00 USD | deriv |
| 08 Apr 2022 | GRANT_AWARD | Ovid Therapeutics Inc. | 87,498 | 0.00 USD | deriv |
| 03 Feb 2022 | GRANT_AWARD | Ovid Therapeutics Inc. | 175,000 | 0.00 USD | deriv |
| 01 Jul 2021 | GRANT_AWARD | Ovid Therapeutics Inc. | 50,000 | 0.00 USD | deriv |
| 25 Nov 2020 | GRANT_AWARD | Ovid Therapeutics Inc. | 44,000 | 0.00 USD | deriv |
| 05 Feb 2021 | GRANT_AWARD | Ovid Therapeutics Inc. | 75,000 | 0.00 USD | deriv |
| 17 Dec 2020 | GRANT_AWARD | Ovid Therapeutics Inc. | 175,000 | 0.00 USD | deriv |
| 19 Jun 2020 | GRANT_AWARD | Ovid Therapeutics Inc. | 50,000 | 0.00 USD | deriv |
| 18 Nov 2019 | GRANT_AWARD | Ovid Therapeutics Inc. | 125,000 | 0.00 USD | deriv |